| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.091 | 0.001 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |